title: Advances in the treatment of erectile dysfunction: what's new and upcoming?
abstract: Erectile dysfunction adversely affects up to 20% of all men and is the most commonly treated sexual disorder. The public health implications of this condition are significant and represent a challenge for our healthcare system. The physiological pathways responsible for erections have been extensively studied, and much advancement has been made since the introduction of phosphodiesterase 5 inhibitors. Newer agents, such as dopaminergic and melanocortin receptor agonists, which target central erectogenic pathways, are under investigation. Newer formulations and delivery methods of existing medications such as alprostadil will also be introduced in the near future. Furthermore, low-intensity shockwave lithotripsy and stem cell regenerative techniques are innovative approaches to the treatment of erectile dysfunction.
authors: Institute of Urology, Lahey Hospital and Medical Center, Burlington, Massachusetts, USA.
authors: Chintan K
authors: CK
authors: Patel
authors: Institute of Urology, Lahey Hospital and Medical Center, Burlington, Massachusetts, USA.
authors: Nelson
authors: N
authors: Bennett
keywords: erectile dysfunction; erectile dysfunction treatment; public health